Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
03/2003
03/18/2003US6534523 Racemates, diastereoisomers and optical isomers of a compound of formula (I): synthesis, compositions and methods for the treatment of hepatitis C virus (HCV) infection and intermediates
03/18/2003US6534495 Anticoagulants that prevent thrombin-related diseases.
03/18/2003US6534493 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
03/18/2003US6534038 Ternary ligand complexes useful as radiopharmaceuticals
03/13/2003WO2003020751A2 Homing peptides
03/13/2003WO2003020748A1 Anti-cancer cyclopenta[g]quinazoline compounds
03/13/2003WO2003020223A2 A cancer treatment system
03/13/2003WO2002064091A3 Melanocortin metallopeptides for treatment of sexual dysfunction
03/13/2003WO2002060926A3 Hepatitis c tripeptide inhibitors
03/13/2003WO2002050019A3 Diamines as modulators of chemokine receptor activity
03/13/2003US20030050331 Cytotoxic agents
03/13/2003US20030050249 Complexes of alpha-6 integrin subunits with small peptides and methods for treating indications resulting from modulation of integrin-mediated responses by altering signal transduction
03/13/2003US20030050248 Novel amino acid and peptide inhibitors of Staphylococcus virulence
03/13/2003US20030050247 Peptides which are modified with at least one hydrocarbyl group and which possess antimicrobial acitivity
03/13/2003US20030050246 Peptides having antiangiogenic activity
03/13/2003US20030050242 Protein polymerization inhibitors and methods of use
03/13/2003US20030049685 Synthetic antigens for the detection of antibodies to hepatitis C virus
03/13/2003CA2459796A1 Homing peptides
03/12/2003EP1290447A2 Peptide potentiation of acid-sensory ion channel in pain
03/12/2003EP1290032A2 Antibodies against particular forms of propsa and use thereof in immunoassays
03/12/2003EP1290012A2 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
03/12/2003EP1290011A1 Melphalan derivatives and their use as cancer chemotherapeutic drugs
03/12/2003EP1290010A1 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof
03/12/2003EP1289951A1 Growth hormone secretagogues
03/12/2003EP1289526A1 Melanocortin receptor agonists
03/12/2003EP1222199A4 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent
03/12/2003EP1187848A4 Annexin derivatives with endogenous chelation sites
03/12/2003EP0934064B1 Thrombin inhibitors
03/12/2003CN1402706A Antidiabetic agents
03/12/2003CN1402643A Integrin-mediated drug targeting
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531490 Production of agglomerates of inogatran and the compound inogatran anhydrate
03/11/2003US6531486 Reacting quinapril or acid addition salt thereof with alkaline magnesium compound in presence of solvent to form quinapril magnesium
03/11/2003US6531474 Inhibitors of caspases
03/11/2003US6531467 Inhibition of inflammation using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
03/11/2003US6531452 Peptide-like and peptidomimetic compounds that inhibit enzymatic activity of picornaviral 3C proteases and inhibit picornavirus replication
03/11/2003US6531449 Hexahydropyrazolo[4,3,-c]pyridine metabolites
03/06/2003WO2003018758A2 Reagents and methods for smooth muscle therapies
03/06/2003WO2003018636A2 Chimaeric peptides of insulin, their compositions and use in treating diabetes
03/06/2003WO2003018606A2 Casein derived peptides and uses thereof in therapy
03/06/2003WO2003018539A1 Amphoteric lipid compound and use thereof
03/06/2003WO2003000198A3 Selective neuronal nitric oxide synthase inhibitors
03/06/2003WO2002100844A3 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/06/2003WO2002085840A9 Process for producing n-formylamino acid and utilization thereof
03/06/2003WO2002047671A3 Lactam compound to inhibit beta-amyloid peptide release or synthesis
03/06/2003WO2002004423A8 Thrombin inhibitors comprising an aminoisoquinoline group
03/06/2003WO2001086293A8 A method for designing and screening random libraries of compounds
03/06/2003US20030045704 Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes
03/06/2003US20030044959 Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes
03/06/2003US20030044502 Sweetener compositions containing aspartyl dipeptide ester compounds
03/06/2003US20030044402 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
03/06/2003US20030044399 Method of treatment
03/06/2003CA2458924A1 Casein derived peptides and uses thereof in therapy
03/06/2003CA2458866A1 Compositions and methods of treating diabetes
03/06/2003CA2458574A1 Reagents and methods for smooth muscle therapies
03/05/2003EP1288224A1 Therapeutic peptide derivatives
03/05/2003EP1288223A1 Therapeutic peptide derivatives
03/05/2003EP1287018A2 Thrombin inhibitors
03/05/2003EP1286989A2 Prodrug of an ice inhibitor
03/05/2003EP1286673A2 Ligands of integrin receptors
03/05/2003EP1286590A2 Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or beta-sheet rich pathological precursor thereof
03/05/2003EP0645398B1 Method of crystallizing n?2 -((s)-1-ethoxycarbonyl-3-phenylpropyl)-n?6 -trifluoroacetyl-l-lysyl-l-proline
03/05/2003CN1400218A Biological active peptide whose sequence number is 19
03/05/2003CN1400217A Biological active peptide whose sequence number is 20
03/04/2003US6528675 Cyanohydrin ethers and esters as high-sensitivity enzyme substrates
03/04/2003US6528514 Pyrimidin-4-one-5-amino-3-alkylcarboxamidomethyl compounds
03/04/2003US6528506 Viability of organs transplants
03/04/2003US6528505 Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
03/04/2003US6528503 Anticoagulants
03/04/2003US6528275 Substrates and inhibitors of proteolytic enzymes
02/2003
02/27/2003WO2003016336A1 Novel method for synthesis of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxylic acid derivatives and use for synthesis of perindopril
02/27/2003WO2003016335A2 Irreversible cysteine protease inhibitors of legumain
02/27/2003WO2003016302A1 Diamine derivatives
02/27/2003WO2003016273A2 Peptide arginals and methods for treating disseminated intravascular coagulation
02/27/2003WO2003015706A2 Borinic acid protease inhibitors
02/27/2003WO2002088172A3 Pentapeptide compounds and uses related thereto
02/27/2003WO2002074050A3 Asymmetric synthesis of (s, s, r)-(-)-actinonin and its analogs and uses therefor
02/27/2003WO2002068592A3 Non-racemic hexafluoreleucine, and methods of making and using it
02/27/2003WO2002049577A3 Analogues of thiocoraline and be-22179
02/27/2003WO2001097861A3 Vitronectin receptor antagonist pharmaceuticals
02/27/2003US20030040485 For use in theray
02/27/2003US20030040483 Compounds with growth hormone releasing properties
02/27/2003CA2457436A1 Peptide arginals and methods for treating disseminated intravascular coagulation
02/27/2003CA2456841A1 Cyclohexyl and piperidine diamine derivatives useful as activated blood coagulation factor x inhibitors
02/26/2003EP1284991A2 Synthesis of n-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester using oxazolidinone derivatives
02/26/2003EP1284990A2 Synthesis of n-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester by reductive alkylation and crystallization/isolation in aqueous methanol
02/26/2003EP1150976B1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase
02/26/2003EP1021424B1 Thiadiazole amide mmp inhibitors
02/26/2003EP0929571B1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
02/26/2003EP0832068B1 Stable reagents for the preparation of radiopharmaceuticals
02/26/2003CN1398894A Bioactive peptide No.26
02/26/2003CN1398893A Bioactive peptide No.27
02/26/2003CN1398892A Bioactive peptide No.28
02/26/2003CN1398891A Bioactive peptide No.12
02/26/2003CN1398890A Bioactive peptide No.13
02/26/2003CN1398889A Bioactive peptide No.18
02/26/2003CN1398888A Bioactive peptide No.29
02/26/2003CN1398887A Bioactive peptide No.11
02/26/2003CN1398886A Bioactive peptide No.17
02/26/2003CN1398885A Bioactive peptide No.7
1 ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 ... 307